Broncus Holding (2216) Fundamentals 2026 — Revenue Analysis | SniperIQ
Broncus Holding (2216) is a CN-listed Healthcare company in Medical - Devices with a market capitalization of HK
Broncus Holding's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 0.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
Broncus Holding runs a net profit margin of -10273.0%, a gross margin of -1585.1%, and an operating margin of -14017.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
Broncus Holding reported revenue of